Freedom of Information

Title
Prescribing HIV and pre-exposure prophylaxis
Reference Number
RF23-399
Request Details
  1. How many patients were treated in the last 6-month period with Truvada or generic emtricitabine / tenofovir disoproxil fumarate for HIV treatment?
  2. How many patients were treated in the last 6-month period with Truvada or generic emtricitabine / tenofovir disoproxil fumarate for Pre-exposure prophylaxis (PrEP)?
  3. How many packs of Truvada or generic emtricitabine / tenofovir disoproxil fumarate were dispensed in latest 6-month period for HIV treatment?
  4. How many packs of Truvada or generic emtricitabine / tenofovir disoproxil fumarate were dispensed in latest 6-month period for Pre-exposure prophylaxis (PrEP)?
  5. How many packs of Descovy (tenofovir alafenamide / emtricitabine) were dispensed in latest 6-month period for HIV treatment?
  6. How many packs of Descovy (tenofovir alafenamide / emtricitabine) were dispensed in latest 6-month period for Pre-exposure prophylaxis (PrEP)?
Response
  • rf23-399-response-1694427155.pdf
    • Date of Disclosure
    11/09/2023